Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,067,492
+$236,020 QoQ
Shares Held
890
-1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#3,086
of 4,605 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Family Manage LLC holds $23,478,755 across 9 Drug Manufacturers - General names. LLY ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
43,515 | $11,051,504 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,626 | $4,449,441 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,547 | $3,732,967 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
20,516 | $1,182,131 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
890 | $1,067,492 | |
| 6 | ABBV |
AbbVie Inc.
|
4,143 | $1,042,544 | |
| 7 | AMGN |
Amgen Inc
|
1,027 | $371,897 | |
| 8 | PFE |
Pfizer Inc
|
15,274 | $367,797 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,067,492 | 890 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $831,472 | 904 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $830,727 | 773 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $295,281 | 387 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $405,355 | 520 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $415,432 | 503 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $387,544 | 502 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $501,442 | 566 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,615,182 | 3,993 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,943,022 | 3,783 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||